Literature DB >> 4057404

Prognostic factors in localized prostatic carcinoma.

J E Pontes, Z Wajsman, R P Huben, R M Wolf, L S Englander.   

Abstract

Serial histological sections were performed in 54 radical prostatectomy specimens in an attempt to identify prognostic factors responsible for dissemination of prostatic cancer. Factors considered in the study included clinical versus pathological staging, histological grading of the biopsy specimen compared to the final pathological result, intraprostatic tumor distribution and deoxyribonucleic acid analysis of the tumor by flow cytometry in the last 33 cases. In patients with clinical stages A2 and B1 disease pathological findings were in accord in 78 per cent (11 of 14). However, only 3 of 40 patients with clinical stage B2 tumor had pathological stage B2 disease. Histologically, 72 per cent of the tumors were bilateral. Microscopic involvement of the capsule per se did not appear to influence lymph node invasion, since only 1 of 27 patients with microscopic capsular involvement had pelvic lymph node metastasis. However, 9 of 13 patients with seminal vesicle involvement had pelvic lymph node metastasis. The addition of flow cytometry to the Gleason score improves the predictive value of histological grade in higher stage lesions.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4057404     DOI: 10.1016/s0022-5347(17)47659-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Flow cytometric analysis of cellular DNA in human prostate cancer: relationship to 5 alpha-reductase activity of the tissue.

Authors:  F K Habib; A Bissas; W A Neill; A Busuttil; G D Chisholm
Journal:  Urol Res       Date:  1989

2.  Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen.

Authors:  M Koutsilieris; P Lembessis; V Luu-The; A Sourla
Journal:  Clin Exp Metastasis       Date:  1999       Impact factor: 5.150

Review 3.  Coumarin (1,2-benzopyrone) for the treatment of prostatic carcinoma.

Authors:  J L Mohler; B T Williams; I M Thompson; M E Marshall
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

4.  The translational landscape of mTOR signalling steers cancer initiation and metastasis.

Authors:  Andrew C Hsieh; Yi Liu; Merritt P Edlind; Nicholas T Ingolia; Matthew R Janes; Annie Sher; Evan Y Shi; Craig R Stumpf; Carly Christensen; Michael J Bonham; Shunyou Wang; Pingda Ren; Michael Martin; Katti Jessen; Morris E Feldman; Jonathan S Weissman; Kevan M Shokat; Christian Rommel; Davide Ruggero
Journal:  Nature       Date:  2012-02-22       Impact factor: 69.504

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.